🌍 This #WorldPIWeek2025, check out this recent article exploring advances in immunoglobulin therapies for Primary Immunodeficiencies

This trial evaluated the #pharmacokinetics, safety, tolerability & efficacy of #Ig20Gly administered weekly & every 2 weeks: bit.ly/4cxNst8